Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. India Glycols's Revenue for the
three
months ended in Jun. 2026 was ₹11,304 Mil. India Glycols's average Accounts Receivable for the
three
months ended in Jun. 2026 was ₹3,514 Mil.
Hence, India Glycols's Receivables Turnover for the
three
months ended in Jun. 2026 was 3.22.
India Glycols (BOM:500201) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
India Glycols Receivables Turnover Related Terms
India Glycols Receivables Turnover Historical Data
* Premium members only.
The historical data trend for India Glycols's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:500201 vs DOW: Receivables Turnover Comparison
For the Chemicals subindustry, India Glycols's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where India Glycols's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
India Glycols (BOM:500201) has a Receivables Turnover of 3.22 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on India Glycols and its competitors. According to the industry distribution chart, India Glycols ranks #217 out of 1580 companies in the Chemicals industry, placing it in the top 13.7%.
Is India Glycols' Receivables Turnover too high?
India Glycols' current Receivables Turnover is 3.22. The Chemicals industry median Receivables Turnover is 5.64. India Glycols' value of 3.22 is 42.9% below this industry median. Based on the distribution chart, India Glycols ranks #217 out of 1580 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Receivables Turnover compare to DOW?
According to the Chemicals industry distribution chart, India Glycols ranks #217 out of 1580 companies for Receivables Turnover. This places India Glycols in the top 14% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.64. India Glycols' value of 3.22 is 42.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.64, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. India Glycols's current Receivables Turnover of 3.22 is 42.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on India Glycols and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. India Glycols's current Receivables Turnover is 3.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹796.12, compared to a current price of ₹1,138.60 — trading 43% above its estimated fair value. The current Receivables Turnover is 3.22 and 42.9% below the Chemicals industry median of 5.64. India Glycols' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For India Glycols (BOM:500201), the current Receivables Turnover is 3.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is India Glycols (BOM:500201) Overvalued in 2026?
Based on GuruFocus' analysis, India Glycols stock appears to be overvalued.
The current stock price of ₹1,138.60 is trading 43% above its estimated GF Value™ of ₹796.12.
GuruFocus considers India Glycols to be Significantly Overvalued.
Key valuation signals for BOM:500201:
Receivables Turnover: 3.22
GF Value™: ₹796.12 vs. price of ₹1,138.60 (43% above fair value)
Industry Position: 42.9% below the Chemicals median (#217 of 1580)
No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score
Get the complete analysis for BOM:500201
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500201 has been successfully added to your 
